[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
October 3, 2007

Incorrect Disclosure Information in: Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

JAMA. 2007;298(13):1516. doi:10.1001/jama.298.13.1516

Incorrect Disclosure Information: In the Original Contribution entitled “Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy” published in the July 25, 2007, issue of JAMA (2007;298[4]:405-412), the names of 2 authors were inadvertently transposed for financial disclosures reported on page 411, and the financial disclosures for another author were not reported. The Financial Disclosure information should have read, “Dr Epstein reported receiving research grants from Biotronik, Boston Scientific/Guidant, Medtronic, and St Jude Medical; receiving speakers fees or honoraria from Boston Scientific/Guidant, Medtronic, and St Jude Medical; and serving as an advisor to Boston Scientific/Guidant and St Jude Medical. Dr Daubert reported serving as a consultant for and having equity holdings in Medtronic. Dr Estes reported receiving speakers honoraria from Boston Scientific/Guidant, Medtronic, and St Jude Medical. No other disclosures were reported.”

×